COMPANY INFORMATION

Market Nav

BSE Prices delayed by 5 minutes and NSE Prices delayed by 15 minutes.

COMPANY PROFILE

The profile page of the company captures the details on Registered Office, Registrar & Share Transfer Agent, Key Officials, Recent News.

Emcure Pharmaceuticals Ltd.

Apr 30 BSE 1679.95 ( -52.90 -3.05%)

Volume12322

Prev. Close 1732.85

Open Price 1735.15

Today's Low / High

1662.10 1735.15

B. Price (Qty.)0.00 (0)

O. Price (Qty.) 0.00 (0)

52 Wk Low / High 950.00

1770.05

Apr 30 NSE 1680.10( -49.80 -2.88%)

Volume278775

Prev. Close 1729.90

Open Price 1730.00

Today's Low / High

1660.90 1734.90

B. Price (Qty.)0.00 (0)

O. Price (Qty.) 0.00 (0)

52 Wk Low / High

983.00 1769.00

Registered Address

Registered & Corporate Office : Plot No. P-1 & P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi,

Pune, Maharashtra - 411057

Tel: 020-35070033, 35070000

Fax: 020-35070060

Email : investors@emcure.com

Website : http://www.emcure.com

Registrar Details

MUFG Intime India Pvt. Ltd.

C 101, 247 Park, L.B.S. Marg, Vikhroli (West)

Mumbai,400083,Maharashtra

Tel : 022-49186270

Fax : 49186060

Key Officials

Name	Designation
Mr. Satish Ramanlal Mehta	Managing Director & CEO
Mr. Chetan Rajendra Sharma	Co. Secretary & Compl. Officer

Other Details

Business Group	Not Applicable
BSE Code	544210
NSE Code	EMCUREEQ
Listings	BSE , BSE , NSE
ISIN No.	INE168P01015

Date	Headline
28/04/2026	Emcure Pharma. - Analysts/Institutional Investor Meet/Con. Call Updates
28/04/2026	Emcure Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
28/04/2026	Emcure Pharma. - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For The Qua
27/04/2026	Emcure Pharma. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 201